Characterization of a novel fusion gene EML4-NTRK3 in a case of recurrent congenital fibrosarcoma

Tannenbaum-Dvir, Sarah; Glade Bender, Julia L.; Church, Alanna J.; Janeway, Katherine A.; Harris, Marian H.; Mansukhani, Mahesh M.; Nagy, Peter L.; Andrews, Stuart J.; Vundavalli, Murty V.; Kadenhe-Chiweshe, Angela; Connolly, Eileen Patricia; Kung, Andrew L.; Cruz, Filemon S. Dela

We describe the clinical course of a recurrent case of congenital fibrosarcoma diagnosed in a 9-mo-old boy with a history of hemimelia. Following complete surgical resection of the primary tumor, the patient subsequently presented with bulky bilateral pulmonary metastases 6 mo following surgery. Molecular characterization of the tumor revealed the absence of the prototypical ETV6-NTRK3 translocation. However, tumor characterization incorporating cytogenetic, array comparative genomic hybridization, and RNA sequencing analyses, revealed a somatic t(2;15)(2p21;15q25) translocation resulting in the novel fusion of EML4 with NTRK3. Cloning and expression of EML4-NTRK3 in murine fibroblast NIH 3T3 cells revealed a potent tumorigenic phenotype as assessed in vitro and in vivo. These results demonstrate that multiple fusion partners targeting NTRK3 can contribute to the development of congenital fibrosarcoma.


  • thumnail for Tannenbaum-Dvir S et al Mol Case Stud-2015.pdf Tannenbaum-Dvir S et al Mol Case Stud-2015.pdf application/pdf 744 KB Download File

Also Published In

Molecular Case Studies

More About This Work

Academic Units
Pathology and Cell Biology
Radiation Oncology
Published Here
August 27, 2019